SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
Report by Issuer of Securities Quoted on NASDAQ
Interdealer Quotation System
Filed pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 and Rule 13a-176
or 15d-17 thereunder
Pharmos Corporation
______________________________________________
(Exact name of issuer as specified in charter)
2 Innovation Drive, Alachua, FL 32615
________________________________________
(Address of principal executive offices)
Issuer's telephone number, including area code 904/462-1210
____________
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in
the number of shares outstanding:
1. Title of security: Common Stock, par value $.03 per share
2. Number of shares outstanding before the change: 29,229,969
3. Number of shares outstanding after the change: 30,709,169
4. Effective date of change: December 12, 1996
5. Method of change:
Specify method (such as merger, acquisition, exchange,
distribution, stock split, reverse split, acquisition of stock
for treasury, etc.): private placement issuance
Give brief description of transaction: On December 12, 1996, the
Company issued 1,479,200 shares of unregistered Common Stock in a
private placement transaction.
II. CHANGE IN NAME OF ISSUER
1. Name prior to change: N/A
2. Name after change: N/A
3. Effective date of charter amendment changing name: N/A
4. Date of shareholder approval of change, if required: N/A
Date: December 20, 1996 /s/ Alan M. Mark
______________________________
Alan M. Mark
Acting Chief Financial Officer
